Hasbro, Inc. (HAS) Stock Price Today
Hershey Trust sells shares ahead of Q3 earnings, retaining control amid price hikes and volume drop.
The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...
Silence Therapeutics jumps 125% after $1.3B acquisition deal with Merck KGaA
Silence Therapeutics' stock surged 125.6% to $19.58 following Merck KGaA's agreement to acquire the RNA-interference drug developer for about $1.3 billion in equity value. Merck will pay $20 per share, a 130% premium over the recent closing price. Ot...
Stocks tumble as Iambic Therapeutics and TCGX Acquisition lead losses amid IPO and merger news.
On October 19, 2026, several stocks saw significant declines. Iambic Therapeutics dropped 31.4% but stayed just above its IPO price of $16 after raising $150 million. TCGX Acquisition fell 18.5% following its announcement of a merger with TriGemX Bio...
Trading resumes for GoldCoast Resource Corp. on Canadian markets after regulatory halt.
Trading in all issues of GoldCoast Resource Corp. (symbol GCR) has resumed at 8:00 AM ET following a temporary halt imposed by the Canadian Investment Regulatory Organization (CIRO). Such halts are used to maintain fair and orderly markets. CIRO over...
Equity Bancshares director buys shares amid strong Q3 earnings and dividend hike
Equity Bancshares director Leon Borck increased his stake by purchasing 380 shares at $48.78 each, signaling confidence after the company reported strong Q3 results. The bank posted a net income of $26.8 million and core earnings of $1.40 per diluted...
Trading halt imposed on Bighorn Metals Corp. shares by Canadian regulator CIRO.
The Canadian Investment Regulatory Organization (CIRO) has temporarily halted trading of all shares of Bighorn Metals Corp. (symbol HRNY) as of 1:10 PM ET on October 19, 2026. The halt is pending further information from the company and aims to maint...
FDA approves Jemperli as first immunotherapy for advanced MSI-H/dMMR rectal cancer, avoiding chemo and surgery.
The FDA has approved Jemperli (dostarlimab) as the first immunotherapy for adults with stage II and III MSI-H/dMMR locally advanced rectal cancer. This approval is based on the AZUR-1 trial showing 68% of patients achieved complete clinical response ...
Ethereum-based crypto Pepeto nears Binance listing as Cardano eyes 6x price rise by 2026
Ethereum-based crypto Pepeto is in its final presale stages ahead of a Binance listing, with rapid investor interest driving record presale speed. Pepeto addresses issues Cardano aimed to fix, such as high fees and network congestion, offering zero-f...
EyePoint Pharma shares plunge 80% after Phase 3 trial failure for DURAVYU in eye disease
EyePoint Pharmaceuticals' stock dropped nearly 80% after its Phase 3 LUCIA trial for DURAVYU in wet age-related macular degeneration failed to meet the primary endpoint of non-inferiority to the control drug aflibercept. Despite missing this key goal...
CanCambria Energy to present at Kinvestor Day 2026 virtual conference on Oct 22
CanCambria Energy Corp., a Canadian exploration and production company specializing in tight gas, will present at the Kinvestor Day 2026 Virtual Investor Conference on October 22. Larry Busnardo, VP of Investor Relations, will deliver the presentatio...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.